Can-Fite BioPharma CANF
NYSE CANF
$1.88 -0.01 (-0.80%)
As of: Oct 21, 2026 · 11:07 AM EDT

Can-Fite BioPharma (CANF) Current Taxes (2016 - 2017)

Updated

Can-Fite BioPharma's Current Taxes was $1.48 million in Q4 2017, down 69.2% from $4.8 million a year earlier.

Analysis

Can-Fite BioPharma (CANF) Current Taxes (2016 - 2017) Analysis & Trends

  • In earlier years, Current Taxes was $4.8 million in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn -
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 1.05 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn -
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 4.22 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 2.31 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 1.47 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn -
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 653.00 Mn
10 Can-Fite BioPharma 1.54 Mn -18.16 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 1.48 Mn
Dec 31, 2016 4.80 Mn
API Access

Can-Fite BioPharma Current Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-taxes&ticker=CANF&period=max&api_key=YOUR_API_KEY